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 Oral lesions are a common manifestation of human 
immunodeficiency Virus (HIV) infection, with up to 90% of HIV 
infected patients developing an oral lesion during the course of their 
HIV disease1.   These oral lesions are often an early finding in HIV 
infection and are useful markers of disease progression and immune 
suppression.2  
 
 Common HIV related oral conditions include candidiasis,  
gingivitis,  intraoral pigmentation, periodontitis,  oral hairy 
leukoplakia, ulcers, Kaposi`s sarcoma, Non Hodgkin`s lymphoma, 
salivary gland disease including xerostomia and 
sialadenitis3 , 4 .Opportunistic infections play an important role in 
immunocompromised patients.  Among the viral opportunistic 
pathogens, the Human Herpes Group (HHV) has been implicated in 
various oral lesions5. In the HHV group, Cytomegalovirus (CMV) of 
the Herpesvirinae subfamily has been studied the least.  Although 
most CMV infections are asymptomatic, certain patient groups are 
at increased risk in developing serious illness. This virus remains 
the leading cause of congenital viral infection and a significant 
cause of transfusion-acquired infections in patients who are 
immunocompromised. It  is  a frequent contributor to morbidity and 
mortality among organ transplant recipients as well as subjects  
infected with HIV5 ,6 , 7 . CMV infection is also believed to accelerate 
the course of HIV disease to the Acquired Immunodeficiency 
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Syndrome (AIDS). CMV disease typically occurs when latent virus 
reactivates in AIDS patients with CD4 cells less than 1002 8.   
CMV is a well known pathogen causing various systemic disorders. 
Delayed diagnosis can lead to complications including CMV 
retinitis ,  pneumonia,  hepatitis ,  encephalitis and leucopenia of which 
CMV retinitis  is the most commonly manifested one11. 
 
 Studies from our centre have reported a significant percentage 
of ulcers among immunocompromised persons, some being herpetic 
and the others being apthous and the rest being non specific in 
origin3.  It has been postulated that CMV plays an important role in 
the pathogenesis of ulcerations of the mucocutaneous and the 
gastrointestinal tract and causes salivary gland dysfunction26.  Few 
studies have linked the role of CMV to its intra oral manifestations, 
the most common being the formation of non specific oral ulcers. 
Clinically, CMV-associated ulcers  are non-specific and involve 
either the keratinized or non keratinized tissues. Microscopically, at 
certain times, typical cytomegalic inclusion bodies can be seen7.  
 
 While there are a very few studies where CMV was detected 
in ulcers of the mucocutaneous region, there are no documented 
evidences linking the viral load to non specific ulcers in the oral 
cavity. Thus, this study attempts to ascertain the efficacy of the 
normally used techniques such as Polymerase Chain Reaction (PCR) 
as a diagnostic tool. As CMV commonly manifests itself as CMV 
retinitis,  this criteria has been used to select this study group. To 
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further aid in the accuracy and sensitivity of the study, Real time 
polymerase chain Reaction (PCR) was been used as a diagnostic tool 
as it  has shown to be rapid and effective in the diagnosis of CMV 
related ocular diseases5 1.    Efforts of correlation between non 
specific intra oral ulcers, the time lag till  CMV retinitis develops 
and detecting the viral load by Real Time PCR in compromised 
patients can aid in diagnosing and starting proper antiviral drugs at 
the right time thereby preventing the disease to reach advanced 
stages which often have fatal consequences1 3 ,14 . 
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AIM AND OBJECTIVES: 
1. To assess and quantify the Cytomegalovirus (CMV) carriage 
in HIV seropositive and seronegative patients by Real Time 
PCR for CMV morphologically transforming region (mtr II) 
sequence 
2. To correlate its  presence with oral findings. 
 
HYPOTHESIS:                                                                                                
 HIV seropositive and seronegative patients with CMV 
retinitis  have a detectable CMV  antigen level in their saliva. 
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STUDY DESIGN: 
 A cross sectional study was done to detect and quantify CMV 
in unstimulated saliva from HIV seropositive and seronegative 
individuals using quantitative Real Time PCR technique for CMV 
morphologically transforming region (mtr II)  sequence. 
 
STUDY GROUPS: 
Group I: Study group (n = 5)  
 HIV seropositive patients diagnosed with CMV retinitis and 
/or nonspecific oral ulcers 
1. Human Immunodeficiencey Virus seropositivity confirmed by 
Western Blot/ ELISA  
2. CMV retinitis diagnosed as per the recommended diagnostic 
criteria* ,  of Sankara Netralaya   
*Indirect Ophthalmoscopy and Slit Lamp Technique for 
Typical Cases 
    
Group II:  Study group (n = 5) 
 HIV seronegative patients clinically diagnosed with retinitis/  
nonspecific oral ulcers 
 
EXCLUSION CRITERIA: 
•  Patients on antiviral drugs to treat CMV infection were not 
included in either Group I or Group II*.   (APPENDIX 1) 
• Ulcers caused by trauma (mechanical,  chemical or thermal) or 
as a result of herpetic stomatitis were not considered 
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STUDY SETTING: 
 Saliva samples were collected from the patients attending the 
outpatient wing of RAGAS - YRG Care, VHS, and Sankara 
Netralaya, Vision Research Foundation (VRF), Chennai.  
 
 Demographic details of the patient,  including the name, age,  
gender, habits,  route of HIV transmission, past medical history, 
routine blood count and list of current medications taken by the 
patient were recorded.  
 
 Ethical clearance was obtained from the institutional review 
board of Ragas Dental College and YRG-CARE, Chennai 
 
 An informed consent formatted for both seropositive and 
seronegative patients was obtained. 
 
 A thorough oral examination was done by a trained dental 
surgeon and the findings were recorded in a pre-structured case 
sheet.  Saliva samples were collected from patients, and stored at -
70o  Celsius in the Department of Oral & Maxillofacial Pathology at 
Ragas Dental College & Hospital.   
 
 DNA extraction and Real Time PCR was conducted in the 
Sankara Netralaya, VRF, Chennai 
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ARMAMENTARIUM: 
¾ For  patient examination and sample collection  
•  Gloves 
•  Mouth mask 
•  50 ml sample collection containers 
•  Normal saline 
•  Wooden spatula 
 
Diagnosis of CMV retinitis by Indirect Opthalmoscopy/ slit lamp 
technique: 
 All the patients were diagnosed with CMV retinitis by an 
ophthalmologist by the method of indirect split lamp fundoscopy or 
slit  lamp technique which detects retinal detachment in the posterior 
segment of the eye which is responsible for vision.  
 
SALIVA COLLECTION: 
1. Patients are asked to have their breakfast by 8 A.M and then 
to abstain from eating anything for 2 hours. Saliva samples 
are collected between 10 A.M TO 12 noon, to reduce diurnal 
variations. 
2. The patient is asked to sit  straight in the dental chair,  with 
head tilted in the front and instructed not to speak or swallow 
or do any head movements during the procedure. 
3. At the beginning the patient is asked to swallow any saliva, if 
present, in the mouth. 
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4. After this the patient is instructed to spit in a presterile 
graduated container every minute for 10 minutes.  
5 ml of saliva was pipetted out for CMV analysis and the rest 
stored at -70 degree Celsius. 
 
Laboratory Technique 
Detailed methodology 
• DNA EXTRACTION 
 
QIAGEN kit method of DNA extraction:  
Reagents: 
a)  Proteinase K 
b) Lysis buffer (AL buffer) 
c)  Ethanol 
d) Washing buffer-1 (AW1 buffer) 
e)  Washing buffer-2 (AW 2 Buffer) 
f) Elution buffer  (AE Buffer) 
 
 Take the saliva samples from the deep freezer and keep them 
for thawing till  they reach room temperature. 
• Take 1500μl  saliva in a 1.5ml micro centrifuge tube. 
•  Centrifuge for 5 minutes at 13000rpm and then discard 1200μl  
of the supernatant. 
• Add 900μl of lysis buffer and mix by inversion method. 
• Incubate the tube for 5 minutes at room temperature. 
• Centrifuge at 1300 rpm for 5 minutes and discard supernatant.  
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• Add 100 μl  lysis buffer to resuspend the cell pellet .  
• Add 200μl GB buffer to tube and mix by vortexing.  
• Incubate the mixture at room temperature for 10 minutes until  
sample lysate is clear.  During incubation, invert the tube every 3 
minutes.  
• Preheat required elution buffer (200μl  /  sample) in a 70°  C water 
bath (for DNA elution). 
• Add 200μl  of ethanol (96-100%) to sample lysate and mix 
immediately by vortexing for 10 seconds. 
• Place a GD (a tube with a sieve) column in 2ml collecting tube. 
• Apply the total mixture (including any precipitate) from previous 
step to GD column. 
• Close the cap and centrifuge at 13000rpm. 
• Add 200μl  of  GB buffer and centrifuge at 6000rpm for 5 
minutes.  
• Add 400 μ l  of W1 buffer into GD column and centrifuge at  
13000 rpm for 30 seconds. 
• Discard the flow-through and place GD column back in the 2ml 
collecting tube. 
• Add 600 μl  of wash buffer into GD column. 
•  Centrifuge at 13000 rpm 30 seconds, discard the flow-through 
and place the GD column back in the 2ml collecting tube. 
• Centrifuge at 13,000 rpm for 5 minutes to dry column matrix. 
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• Transfer dried GD column into clean 1.5 ml micro-centrifuge 
tube. 
• Add 100 μl  of preheated elution buffer into the centre of column 
matrix. 
• Stand at room temperature for 5 minutes until  elution buffer is  
absorbed by the matrix. 
• Centrifuge at 13000 rpm for 30 seconds to elute purified DNA. 
• Store the extracted DNA at - 4 ° C till  further use. 
 
REAL TIME PCR TECHNIQUE  
 Real-time PCR  is used to amplify and simultaneously 
quantify a targeted DNA molecule. It  enables both detection and 
quantification of one or more specific sequences in a DNA sample. 
The procedure follows the general principle of polymerase chain 
reaction; its key feature is that the amplified DNA is detected as the 
reaction progresses in real time, where the product of the reaction is 
detected at its  end.  
 
Two common methods for detection of products in real-time PCR 
are: 
1. Non-specific fluorescent dyes that intercalate with any 
double-stranded DNA, and  
2.  Sequence-specific DNA probes consisting of oligonucleotides 
that are labeled with a   fluorescent reporter which permits 
detection only after hybridization of the probe with its  
complementary DNA target.  
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PRINCIPLE OF REAL TIME PCR: 
 In this study, sequence-specific DNA probes labeled with a 
fluorescent reporter which permits detection only after 
hybridization of the probe with its complementary DNA target is  
used, which is the Taqman Probe. 
  
 Real Time PCR assay uses the Taqman principle. During the 
PCR, forward and reverse primers hybridize to a specific sequence 
product.  A Taqman probe, which is contained in the same reaction 
mixture and which consists of an oligonucleotide labeled with a 5` - 
reporter dye and a downstream, 3` - quencher dye, hybridizes to a 
target sequence within the PCR product. A Taq polymerase which 
processes 5` - 3`exonucease activity cleaves the probe. The reporter 
dye and the quencher dye are separated upon cleavage, resulting in 
an increase in fluorescence for the reporter. Thus, the increase in 
fluorescence is is directly proportional to the target amplification.  
 
FOR QUANTIFYING, THERE ARE TWO BASIC 
REQUIREMENTS: 
a)  The machine: Rotor GeneTM 2000/3000  
b) Quantification kit for CMV: Geno Sen CMV Real Time PCR 
Kit 
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DESCRIPTION AND CONTENTS OF THE QUANTIFICATION 
KIT: 
 The PCR reagent kit constitutes a ready to use system for the 
detection and quantification of CMV using Polymerase Chain 
Reaction (PCR) in the Rotor Gene 2000/3000. The specific master 
mix contains reagents and enzymes for the specific amplification of 
CMV and the direct detection of the specific amplicon in 
fluorescence channel Cycling A.FAM* of the Rotor Gene 2000/3000 
and the Reference Gene on Cycling A.JOE*(APPENDIX 2) 
 
     CONTENTS OF THE CMV REAL TIME PCR KIT 
COLOR CODE CONTENTS 
R 1  CMV supermix* 
R 2 Magnesium solution reagent* 
CMV S1 CMV standard 1 (1 x 105  copies/microlitre) 
CMV S2  CMV standard 2 (1 x 104copies/microlitre) 
CMV S3  CMV standard 2 (1 x 103copies/microlitre) 
CMV S4  CMV standard 2 (1 x 102copies/microlitre) 
CMV S5 CMV standard 2 (1 x 101copies/microlitre) 
W  Molecular grade water 
IC 1 (R 3) IC - 1  (Reagent 3) 
 
 The probes and primers are designed according to the 
standardized design made by Sankara Netralaya and added into the 
supermix. The primers and probes designed are as follows  
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Real-time PCR targeting the morphologically transforming region 
II sequence  is applied onto the DNA extracted from clinical 
specimens and further Real Time PCR assay was carried out.  
 
Primers and probe sequence are:   
• Forward primer: 5’- TTACGCGACCAGATTGCAAGA - 3’  
• Reverse primer: 5’ - TACCTACGTGACCTACCAACG - 3’ 
• Probe: 5’ (6FAM) - CTCCGCCTCACCTTTCATCGAGTAAA-
TAMRA - 3’  
(Standardized by Sankara Netralaya) 
 
STEPS BEFORE THE FINAL RESULTS ARE OBTAINED: 
1. The preparation  for PCR amplification which constitutes the 
preparation of  premix, addition of the standards to the 
extracted DNA 
2. Placing, the 0.2ml PCR tubes into the 36 well rotor,  
programming the ROTOR GENE TM 2000/3000  and the Real 
Time PCR assay 
 
1. PREPARATION FOR PCR AMPLIFICATION: 
• Pipette out and place 24 microlitres of the CMV supermix, 5 
microlitres of CMV magnesium solution and 1 microlitre of 
Reagent 3 Internal Control  in a 0.2ml PCR tubes 
• Pipette 30 microlitres of the premix thus prepared into each 
labeled PCR tube. Then add 20 microlitres of the earlier  
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extracted DNA to each sample and mix well by pippetting it  
up and down. 
• Correspondingly, 20 microlitres of the standards must be used 
as positive control and 20 microlitres of water as a negative 
control. 
• Close the PCR tubes and transfer the CMV tubes into the 
rotor of the ROTOR GENE instrument.  
• The ROTOR GENE software versions require a locking ring 
to be placed on top of the rotor to prevent accidental opening 
of the tubes during the run. 
 
2. PROGRAMMING THE ROTOR GENE TM 2000/3000: 
 The RotorGene TM 2000/3000 PCR program can be divided 
into following steps: 
a)  Setting of general assay parameters & reaction volume 
•  Confirm whether the PCR tubes used are NO DOMED 
PCR tubes by clicking in the box. (Figure1).  
•  To click on the volume buttons to make sure that 50 
microlitre is reflected in the window. (Figure 2).  
•  Then click next and a new window will open. 
b) Thermal Profile & Calibration 
•  Programming the temperature profile is done by 
activating the button EDIT TEMPERATURE PROFILE 
in the next NEW EXPERIMENT WIZARD menu 
window (Figure 3). 
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c)  Cycling profile/ & Initial activation of the Hot Start enzyme 
•  First hold 950 for 10 minutes (Figure 4). 
•  Setting up of denaturation step in the cycling profile 
i.e.  950  Celsius for 15 seconds 
•  Setting up of annealing step in the cycling profile i .e.  
550 Celsius for 20 seconds and defining the data 
acquiring channel 
 (Figure 5). 
•  Setting up of extension step in the cycling profile i .e.  
720  Celsius for 15 seconds (Figure 6). 
d) Cycling for Amplification of DNA 
•  Setting up of number of cycles to 45 cycles in the 
cycling profile (Figure 7). 
e)  Adjustment of the sensitivity of the fluorescence channels 
•  The detection range of the f luorescence has to be 
determined according to the fluorescence intensities in 
the PCR tubes 
f) Starting of the Rotor Gene^TM run. 
3. REAL TIME PCR ASSAY: 
QUANTIFICATION: 
• The light emitted from the dye in the excited state is received 
by a computer and shown on a graph display, such as this, 
showing PCR cycles on the X-axis and a logarithmic 
indication of intensity on the Y-axis. (Figure 8) 
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INTERPRETATION OF A TYPICAL GRAPH 
 The typical result of a real time PCR analysis with a detection 
system based on dyes is an amplification plot with a curve for each 
detector. These are based on probes stained with different 
fluorophore dyes like FAM, ROX, CY5, QUASAR 705 and JOE. The 
probe stained with FAM (APPENDIX 2)  indicates the presence of 
the pathogen in the sample, whereas the JOE‐stained probe 
(APPENDIX 2)  indicates a correct amplification reaction through 
the use of the Internal Amplification Control (IAC), which allows 
the detection of PCR inhibitors, avoiding false negative results. 
Since the level of fluorescence signal is variable depending on the 
dye, a threshold value will be independently set for each curve. The 
amplification signal for each dye will be considered positive 
whenever the detector curve crosses its threshold value. Therefore, 
samples will  be considered positive (presence of the pathogen) 
whenever they display a FAM positive signal.  By contrast,  samples 
will be considered negative (absence of the pathogen) only when the 
FAM signal is negative but the JOE signal is positive. 
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FLOWCHART OF THE REAL TIME PCR PROCEDURE 
DNA EXTRACTION  
 
PREPARATION OF THE PREMIX 
 
ADDITION OF EXTRACTED DNA AND STANDARD 
 
PLACEMENT OF THE PREPARED MIX IN THE ROTOR 
 
PROGRAMMING THE ROTOR 
 
INTERPRETATION OF THE RESULTANT GRAPH 
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STATISTICAL ANALYSIS: 
 The data was entered and analyzed using SPSSTM 10.05 
software. Chi square test was used to find the association between 
the response for the xerostomia inventory in Group and Group II.   
Student`s t  test was used to find the mean difference in the USFR 
between Group I and Group II.  One sample t  test was used to 
calculate the USFR from the reference value. A p < 0.05 was 
considered statistically significant.  
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CYTOMEGALOVIRUS 
CLASSIFICATION, SEROPREVALENCE AND TRANSMISSION: 
 Cytomegalovirus  (from the Greek cyto- ,  "cell",  and -megalo- ,  
"large") is a herpes viral genus of the Herpesviruses group In 
humans it is commonly known as CMV or Human Herpesvirus 564. 
 
 CMV belongs to the Betaherpesvirinae subfamily of 
Herpesviridae, which also includes Roseolovirus. Other 
herpesviruses fall into the subfamilies of Alphaherpesvirinae 
(including HSV 1 and 2 and varicella) or Gammaherpesvirinae 
(including Epstein-Barr virus)64.  All herpesviruses share a 
characteristic abili ty to remain latent within the body over long 
periods. 
 
 CMV infections are frequently associated with salivary 
glands6 4.  CMV infection can also be life threatening for patients  
who are immunocompromised (e.g.  patients  with HIV, organ 
transplant recipients, or neonates) 
 
 CMV is found throughout all geographic locations and 
socioeconomic groups, and infects between 50% and 80% of adults, 
as indicated by the presence of antibodies in much of the general 
population6 5.  Seroprevalence is age-dependent: 58.9% of individuals  
aged 6 and older are infected with CMV while 90.8% of individuals 
aged 80 and older are positive for CMV. CMV is also the virus most 
frequently transmitted to a developing fetus.  
24 
 
 CMV infection is more widespread in developing countries 
and in communities with lower socioeconomic status and represents 
the most significant viral cause of birth defects in industrialized 
countries66.  
 
PATHOGENESIS 
 Most healthy people who are infected by CMV after birth 
have no symptoms6 4. Some develop an infectious 
mononucleosis/glandular fever-like syndrome, with prolonged fever, 
and a mild hepatitis67.  After infection, the virus remains latent in 
the body for the rest of the person's life.  Overt disease rarely occurs 
unless immunity is suppressed either by drugs, infection or old age. 
Initial CMV infection, which often is asymptomatic, is followed by 
a prolonged, inapparent infection during which the virus resides in 
T - cells without causing detectable damage or clinical 
illness.Infectious CMV may be shed in the bodily fluids of any 
infected person, and can be found in urine, saliva, blood, tears,  
semen, and breast milk. The shedding of virus can occur 
intermittently, without any detectable signs or symptoms6 2. 
 
CMV IN IMMUNOCOMPETENT INDIVIDUALS 
Pederson et al  in 1993  made attempts to diagnose reactivation of 
cytomegalovirus from sera of patients with Recurrent Apthous 
Ulcerations (RAU) using specific antibody subclasses (IgG, IgM, 
IgA). The result of the study supported the hypothesis of RAU 
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recurrences of the “minor” type being associated with the 
reactivation of latent CMV34.   
 
Virtanen et al  in 1995  found the possible involvement of 
cytomegalovirus in oral mucosal ulcers by their role in the 
development of ulceration at  other mucosal sites of the 
gastrointestinal tract.  Incisional biopsies from 29 consecutive and 
apparently immunocompetent patients attending the Department of 
Oral Pathology, Finland, were examined for oral ulceration by 
histopathology as well as in situ hybridization with biotinylated 
CMV. The ulcers containing CMV DNA were found on the labial 
mucosa and one on the posterior palatal mucosa. Their results 
indicate that CMV can be found in oral mucosal ulcers in apparently 
immunocompetent adults26. 
 
Wreghitt et al  in 2003 evaluated and discussed various symptoms 
associated with cytomegalovirus infection in 7630 
immunocompetent patients from Cambridge Health Laboratories, 
London. Serum samples were obtained and tested for CMV 
immunoglobulin M. The most frequent symptoms were malaise 
(67%), fever (46%), sweats (46%), and abnormal liver function test 
result (69%)16. 
 
Doumas et al  in 2007 from Greece discussed the relationship of 
Human cytomegalovirus and associated oral and maxillo facial  
disease.  They concluded that CMV associated oral ulcerations were 
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non specific, long lasting, solitary or numerous, painful or painless, 
medium sized, shallow ulcerations1 9.  
 
Rafailidis et al  in 2008 reviewed and retrieved 89 articles reporting 
on severe CMV infection in apparently immunocompetent patients 
and the potential role of antiviral treatment for these infections over 
a period of 57 years. Among these reports,  the gastrointestinal tract 
(colitis) and the central nervous system (meningitis,  encephalitis ,  
and transverse myelitis) were the most frequent sites of severe CMV 
infection. Manifestations from other organ-systems included 
haematological disorders (haemolytic anaemia, thrombocytopenia),  
thrombosis of the venous or arterial vascular system, ocular 
involvement (uveitis),  and lung disease (pneumonitis)15. 
 
CYTOMEGALOVIRUS INFECTION IN 
IMMUNOCOMPROMISED INDIVIDUALS 
 Infection with CMV is a major cause of disease and death in 
immunocompromised patients, including organ transplant recipients,  
patients undergoing hemodialysis,  patients with cancer, patients  
receiving immunosuppressive drugs, and HIV-infected patients.  In 
patients with a depressed immune system, CMV-related disease may 
be much more aggressive. 
 
Patra et al  1999  investigated a total of  6580 endoscopic mucosal 
biopsied from 6323 patients in the 8 year period for CMV inclusion 
bodies from Christian Medical College, Vellore, India. The presence 
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of ulcers were analyzed and confirmed in 54 of patients. Of the 54 
patients with CMV infection, 37 were immunocompromised and 17 
apparently immunocompetent.  The maximum prevalence of 
inclusions was in the oesophageal mucosa in immunocompromised 
individuals. Atypical inclusions were seen more frequently in 
immunocompromised individuals suggesting that the typical  
inclusions are the end result of viral infection and tissue response in 
an immunocompetent host25. 
 
Hosey et al  in 2002  studied whether cytomegalovirus is associated 
with gingival overgrowth in 34 pediatric liver graft recipients  
treated with cyclosporine from Glasgow and Brimingham. An index 
of severity of gingival overgrowth was used to measure the 
prevalence and severity of the gingival overgrowth. There was 
found to be no relationship between CMV and gingival 
overgrowth23. 
 
Tarkan et al  in 2008  reported case of an ulcerative oral lesion in a 
67 year old man with diabetic nephropathy and end stage renal 
disease who was CMV IgG negative from the Department of 
Medicine, Brigham, USA. He received a deceased donor renal 
transplant from a CMV IgG positive donor. The recipient developed 
severe CMV associated oral lesions five months after 
transplantation, one each on the left lower gingiva, right lateral  
tongue and on the buccal mucosa, despite prophylaxis with 
valganciclovir,  and in the absence of detectable CMV viremia. The 
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diagnosis was confirmed after an immunoperoxidase stain using 
anti- CMV antibody and multiple biopsies of the lesions, the 
specimens showed ulceration and viral cytopathic changes 
consistent with CMV, including intranuclear “owl’s eyes”1 7.  
 
CMV AND HIV INFECTION  
Langford et al  in 1990  observed oral ulcerations associated with 
cytomegalovirus CMV infection in four patients with AIDS 
manifestations showing low CD4 counts in Berlin, Germany. Virus 
cultures of urine and saliva samples were positive for CMV in all 
cases. The lesions were characterized by a punched out appearance,  
non indurated, low bleeding tendency and lack of inflammatory 
wall.  Light microscopy revealed granulation tissue containing owl’s 
eye like cells in all  specimens. Presence of CMV was confirmed by 
immunohistochemistry and in situ hybridization3 3. 
 
Berman  et al  in 1990 ,  reported the first case of intrabony CMV in a 
43 year old HIV seropositive white man who developed a recurrent 
swelling of his left jaw after extraction of two carious mandibular 
teeth. He had a history of PCP, Kaposis` Sarcoma and esophageal 
candidiasis.  Resection of a portion of his mandible revealed 
granulation tissue with CMV inclusions in the lesional endothelial  
cells.  After the oral biopsy, the patient developed CMV retinitis. 
They concluded that osteomyelitis should be added to the list  of 
infections caused by CMV in patients with Acquired 
Immunodeficiency Syndrome3 4. 
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Leggot et al  in 1992 reviewed the various clinical oral  
manifestations that occur in HIV positive children from North 
Eastern United States. They reported a number of oral  
manifestations of unknown etiology in persons with HIV infection 
and the most common of these were salivary gland enlargement.  
Parotid gland enlargement was reported to be much more common in 
children than in adults.  They concluded that apthous like ulceration 
and oral lesions associated with thrombocytopenia appear to be 
infrequent in children. Oral manifestations of papillomavirus 
lesions or warts, condyloma acuminatum, histoplasmosis and 
toxoplasma gondii, Cryptococcus neoformans, oral cytomegalovirus 
and mycobacterium avium – intracellulare infections were 
uncommon in the pediatric population32.   
 
Dodd et al  1993  reported a case of oral CMV infection from  a 35 
year old HIV seropositive homosexual man from the University of 
California, San Francisco with CD4 lymphocyte count of 10 cells  
per microlitre. On intra oral examination there was ulceration of the 
gingival mucosa .  Histopathological examination revealed non 
specific mucosal ulcer covered by necrotic material with enlarged 
cells suggesting CMV infection. Immunohistochemical examination 
with anti CMV monoclonal antibody revealed intense nuclear 
staining in some of the cells.  Six weeks after the diagnosis of oral 
ulceration associated with CMV, evidence of CMV retinitis  was 
found3 1. 
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Jones et al  in 1993  reported six examples apart from nine well  
documented examples of intraoral cytomegalovirus infections from 
the University of Florida, New York .They found CMV as one of the 
most common causes of life threatening opportunistic viral 
infections in patients with Acquired Immunodeficiency Syndrome. 
They concluded that is necessary to recognize oral CMV which is an 
uncommon cause of intraoral ulceration in patients with HIV 
disease.  Such a lesion may represent an early sign of disseminated 
CMV infection2 9. 
 
Glick et al  in 1994  reported oral lesions in 454 patients from the 
University of Pennsylvania   who came to an outpatient dental  
clinic, in persons with specific lesion and a CD4 cell count below 
200 cells per microlitre,  They found three cases of intraoral 
cytomegalovirus associated ulcers among their cohort and 69.4% 
had xerostomia. The mean CD4 cell count for patients with 
cytomegalovirus associated ulcerations was 36.7 cells per cubic 
mm2 8.  
 
Greenberg et al  in 1995  studied a group of 31 patients with 
acquired immunodeficiency syndrome with CD4 counts less than 
150 cells per microlitre, these patients were a part of a larger CMV 
study done by Infectious Diseases Division at the School of 
Medicine, University of Pennsylvania. Whole saliva was collected 
for detection of cytomegalovirus deoxyribonucleic acid via the 
Polymerase Chain Reaction. There found a strong statistical 
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relationship between salivary cytomegalovirus DNA and xerostomia 
which suggested that cytomegalovirus may be a cause of salivary 
gland dysfunction in patients with acquired immunodeficiency 
syndrome with low CD4 counts27.  
 
Vargas et al  in 2003  in their retrospective study of 100 patients  
who died with AIDS in Netherland reported 9 patients with CMV 
infection detected by anti CMV antibody. They also stated in their 
conclusion that infections and other lesions of the parotid glands are 
more frequent in advanced AIDS2 1. 
 
Esteban et al  in 2001  investigated and tried to elucidate the 
pathogenetic role of cytomegalovirus in mucocutaneous lesions of 
17 HIV infected patients with CMV from the Department of 
Dermatology, Pathology and Microbiology, Madrid, Spain using 
biopsy specimens from the lesions and analyzing them by light 
microscopy, immunohistochemical and microbiological analysis 
(standard viral culture and shell vial technique). They found that 
most of the lesions where CMV was found were ulcers on perianal,  
genital and perigenital areas. The finding of CMV was confirmed in 
all  cases by light microscopy. They concluded that CMV does not 
play any significant pathogenetic role in the cutaneous lesions 
where it  is found24.   
 
Kempen et al  in 2003  prospectively followed and reported 589 
patients who had CMV retinitis from the John Hopkins CMV 
32 
 
retinitis  cohort in Baltimore, to evaluate the relationship of anti  
cytomegalovirus (CMV) treatment and immune reconstitution in 
response to highly active antiretroviral therapy (HAART) on the 
mortality risk of patients with CMV retinitis and acquired immune 
deficiency syndrome. Patients who used HAART during follow up 
had an 81% lower risk of mortality than patients who did not.  They 
concluded that AIDS and CMV retinitis have a high mortality risk, 
but HAART substantially reduces this risk2 2. 
 
Lambert et al  in 2004  reported a case of a 47 year old man with 
multiple drug resistant Acquired Immunodeficiency Syndrome 
(AIDS) who presented with a ulcer on the right lateral part of the 
heel admitted to the Yale – New Haven Hospital,  Boston. The 
patient had a history of successfully treated CMV retinitis,  with a 
CMV antigenaemia of 2000 U, he also had a CD4 count of 20 cells 
per microlitre with a HIV viral load of 7, 15, 000 copies per ml.   A 
biopsy from that region revealed many large, irregularly shaped 
endothelial cells with large basophilic intranuclear inclusions, in 
some cells surrounded by clear halos. Immunohistochemical studies 
showed CMV antigen reactivity within the endothelial cells.  They 
suggested that the ulcer could be a result of hematogenously 
disseminated infection or a reactivation within the endothelial  
cells2 0. 
 
Majumdar et al  in 2007  reported a case of a 34 year old HIV 1 
seropositive individual from Kolkata,  Eastern India, who was on 
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antiretroviral therapy and his CD 4 count was 114 cells per 
microlitre, complained of bilateral lower limb weakness for 6 weeks 
and symptomatic pallor.  Cytomegalovirus IgG levels were elevated 
at 2.813 mg/dl (< 0.9 Normal).  Bone marrow histopathological 
examination showed a cellular marrow with depressed 
erythropoiesis,  features of dyserythropoiesis,  normal maturation of 
granulocytes, increased megakaryopoiesis and features of dysplasia 
suggestive of CMV infection38. 
 
CMV AND IMMUNE RECONSTITUTION INFLAMMATORY 
SYNDROME 
 Immune reconstitution inflammatory syndrome (IRIS) is  
defined as occurrence or worsening of clinical and/or laboratory 
parameters despite a favourable outcome in human 
immunodeficiency virus surrogate markers12. It was described for 
the first t ime in the late 1990s in HIV-seropositive patients with 
cytomegalovirus retinitis  and Mycobacterium avium complex 
disease following initiation of antiretroviral therapy12.   
 
 A high viral load before initiation of highly active anti  
retroviral therapy (HAART) or a rapid drop in the viral load 
following HAART seems to be an important predictive factor for 
IRIS. Other risk factors include the presence of an active or a sub 
clinical infection by opportunistic pathogens at the time of 
initiation of HAART. IRIS is associated most commonly with 
mycobacterial and CMV infections; therefore the resulting clinical 
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manifestations of this syndrome can be promptly treated if  
recognized at the right time1 2.    
 
Karavellas et al  in 1999  described and prospectively reviewed the 
records of all  patients with CMV retinitis from 1996 – 1998 at the 
University of California, San Deigo. They described a syndrome of 
posterior segment intraocular inflammation that causes visual loss 
in patients with acquired immunodeficiency syndrome and 
cytomegalovirus retinitis.  This syndrome was associated with 
immune recovery mediated by a combination antiretroviral 
treatment including protease inhibitors40.   
 
Cassoux et al  in 1999 discussed and reviewed 325 patients with 
CD4 counts below 50 cells per microlitre by retinal screening 
examination at the primary care level in AIDS clinics in five 
countries of sub-Saharan Africa and in South East Asia. Twenty 
percent of patients had CMV retinitis,  usually not previously 
diagnosed. They concluded that  HAART was highly efficient in 
reducing the HIV viral load and increasing the CD4 T lymphocyte 
count thereby resulting in a prolonged relapse free interval4 1   
 
Meer et al in 2006 retrieved and demonstrated 20 cases of oral 
Kaposi’s sarcoma from the University of Witwatersrand, South 
Africa, and its possible significance to cytomegalovirus infection. 
They histopathologically examined and found that all 20 cases 
showed the presence of HHV8 DNA and five patients showed co 
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infection with CMV sequences in their oral lesions.  They concluded 
that Kaposi’s sarcoma could act as a reservoir for the CMV virus, 
thus providing a source for the virus to spread to other sites as 
immunosuppression worsens4 2.   
 
Heiden et al in 2007  reviewed the available data from Cambodia,  
Africa, Thailand, Myanmar and China, describing the problem of 
CMV retinitis in resource poor settings. According to their 
observations in western countries in the pre HAART era, about 1/3 
of patients with AIDS suffered potentially blinding CMV retinitis .  
Extra ocular CMV infection in the CNS, gastrointestinal tract,  and 
other organs contributed to AIDS related mortality1 8.   
 
Ortega et al in 2007 verified the possible association between 
immune reconstitution inflammatory syndrome (IRIS) and oral 
manifestations in 105 patients from Hospital Carlos Hoya, Mexico. 
Among these patients the mean CD4 count rose from 105.97 to 
330.29, the most common oral manifestation was parotid 
enlargement (57.14%) followed by candidiasis (46.15%). They 
concluded that parotid gland enlargement found in the studied 
population might be an IRIS event3 7. 
 
Kumarasamy et al  in 2008  reviewed the changes in ocular 
manifestations of HIV in the pre – and post – HAART eras in their 
AIDS Research centre at Chennai, India. They described the first 
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two cases, one patient with CMV retinitis and the other with 
endogenous endopthalmitis,  of ocular involvement of HIV36. 
 
Muller et al  in 2010  reviewed and Meta - analyzed to establish the 
incidence and lethality of the syndrome in published reports from 
2000 - 2009 with a range of previously diagnosed opportunistic 
infections, and examined the relation between occurrence and 
degree of immunodeficiency. They found that in patients with 
previously diagnosed AIDS defining illness, IRIS developed in 37. 7 
% of those with cytomegalovirus retinitis35.   
 
DETECTION OF CMV BY POLYMERASE CHAIN REACTION  
Warren et al  in 1992  compared rapid methods for the detection of 
CMV from saliva in congenitally and perinatally CMV infected 
children and compared it  with traditional virus tissue culture. The 
PCR was used to amplify a 300bp segment of the CMV gB gene and 
centrifugation enhanced microtitre culture method with monoclonal 
antibody for the detection of early antigen fluorescent foci was also 
used. Saliva was collected with mouth swabs from children between 
ages of 1 month and 14 years who had either perinatal or prenatal 
CMV infection. In total,  201 samples were tested; 46 were positive 
by both tests,  9 samples showed only antigenemia, 54 samples were 
positive by PCR only, and 102 samples were negative by both tests. 
They concluded that PCR was on average positive for a longer 
period of time5 1.  
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Boland et al 1992  compared the sensitivity and suitability of 
detection of active cytomegalovirus infection by using monoclonal 
antibodies and PCR against CMV antigen in the granulocytes. 19 
heart 2 lung transplant recipients were closely monitored by these 
tests for at least 5 months after transplantation. They concluded that 
both PCR and antigenemia were very sensitive techniques for the 
detection of active CMV reinfection. PCR was also found to be 
positive in patients without further evidence of active CMV 
infection, which indicates that,  after transplantation, CMV DNA can 
be present in peripheral blood granulocytes, even though CMV 
antigen and overt CMV infection cannot be detected5 2.   
 
Correia et al  in 2007  investigated the effect of allogenic 
Hematopoietic stem cell transplantation (HSCT) on cytomegalovirus 
shedding taken from oral mucosal swabs by nested PCR and its  
impact on patient survival.  124 HSCT patients and 124 healthy 
volunteers were included in this study. Oral swabs from the buccal 
mucosa were taken before, after 100 days and 1 year of HSCT. 
While none of the individuals in the control group showed positive 
swabs for CMV, the frequency of positive CMV oral swabs in 
patients at 100 after HSCT was statistically higher than before and 
one year after HSCT. Thus proving that identification of CMV 
might be important for the early diagnosis of CMV infection in allo 
– HSTC4 3.  
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Lucht et al  in 1998  studied and observed the presence of DNA from 
cytomegalovirus and Human Herpesvirus 6, 7 and 8 in the saliva 
from 44 human immunodeficiency virus type 1 infected patients at 
different stages of disease and in 15 healthy HIV seronegative 
controls using nested PCR technique. The most common finding was 
the DNA from both HHV 6 and HHV 7 (detected in 28 of 59 
samples),  followed by DNA from CMV, HHV 6 and HHV 7 (7 of 
59), and HHV 7 alone (7 of 59). They concluded that the detection 
of CMV DNA and HHV 8 DNA in saliva correlated positively with 
the severity of HIV 1 induced immunodeficiency, but the presence 
of CMV DNA did not correlate with any specific oral symptom4 9.   
 
Boivin et al  in 1998  determined CMV DNA load in 
polymorphonuclear leukocytes (PMNL) and plasma samples from 
106 human immunodeficiency virus infected subjects at risk of 
developing CMV disease. The sensitivity, specificity, the positive 
and negative predictive values of qualitative PCR in reaction using  
PMNL for the presence of CMV disease were 100%, 58%, 38% and 
100% respectively compared with 70%, 93%, 74% and 92% for 
qualitative PCR plasma and 93%, 92%, 76% and 98% for 
quantitative PCR PMNL using a cutoff of 16,000 copies per ml.  
They concluded that the best strategy for diagnosing these 
individuals relies on quantitative assessment of the viral DNA load 
in PMNL50. 
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Spector et al  in 1999  studied and demonstrated the presence and 
quantity of CMV DNA within the plasma of 619 patients with 
advanced AIDS using Roche Amplicor assay. They concluded that  
CMV viral load is independent of HIV-1 viral load in predicting 
CMV disease and survival.  Their findings indicate that in patients 
with advanced AIDS, CMV DNA load is an independent marker of 
CMV disease and survival and is more predictive than HIV-1 RNA 
load5 4. 
 
Humar et al  in 1999  prospectively analyzed the clinical use of 
quantitative PCR based plasma viral load for predicting the 
development of active CMV disease in 97 consecutive liver 
transplant recipients from the Department of Medicine, Cananda. 
The optimal cut-off for viral load was in the range of 2000-5000 
copies/ml.  They concluded that determining plasma viral load by 
quantitative PCR was useful for predicting CMV disease and could 
be used in a preemptive strategy55 .  
 
Ammatuma et al  in 2001  determined and studied the prevalence of 
CMV – DNA in oral healthy lingual and buccal cytobrushings from 
the mucosa of HIV infected and renal transplant patients from the 
outpatient clinic of the University of Palermo, Italy. They 
concluded that CMV was less frequently present and if present were 
detectable by PCR from epithelial brushings of buccal mucosa4 8.   
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Rao M et al  in 2002  reviewed the profile of CMV infection and 
disease in the renal transplantation population of the Department of 
Nephrology, Christian Medical College and Hospital,  Vellore. They 
reported the prevalence of clinical CMV disease post transplant at  
about 30 %. Diagnosis of CMV disease was based on clinical and 
virologic oriented criteria such as PCR and IgM positivity, with a 
combination of a CMV like illness in the presence of a laboratory 
marker of active infection3 9. 
 
Madhavan HN et al  in 2003  made an attempt to standardize a 
multiplex PCR (mPCR) from intraocular specimens from patients 
with viral retinitis for the detection of one or more viruses (herpes 
simplex virus, varicella zoster  virus or cytomegalovirus) in order to 
reduce the period of time required for uniplex Polymerase chain 
reaction. Using the uniplex PCR (uPCR) primers, a nested mPCR 
was developed and standardized for the simultaneous detection of 
the viruses; m PCR and u PCR were applied on 9 stored specimens 
and 38 prospective specimens. The specificity and sensitivity of the 
m PCR and u PCR were concordant with that of u PCR. They 
concluded that m PCR is a rapid, specific and sensitive diagnostic 
tool in viral retinitis compared to u PCR, m PCR is less time 
consuming and cost effective46. 
 
Mujtaba et al  2003  made an active attempt to detect active CMV co 
infection in patients with HIV/AIDS using three assays and the 
positivity rates in the two groups compared. They used polymerase 
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chain reaction for immediate early gene of CMV, pp65 antigenaemia 
assay and IgM ELISA to detect the presence of CMV coinfection in 
37 patients with AIDS and 32 healthy HIV seropositive patients.  
Thirty healthy laboratory workers served as normal controls. Of the 
37 patients with AIDS, 12 (32.4%) showed a positive reaction by 
PCR and only 4 patients were positive by the antigenaemia assay. 
None of the controls showed positivity by any of the tests.  The 
difference in PCR positivity rates between HIV seropositive and 
patients with AIDS was significant,  proving PCR as a powerful tool 
for the detection of CMV in blood and is superior to the 
antigenaemia assay74.   
 
Pathanapitoon Kessara et al  in 2005  evaluated the diagnostic 
value of PCR performed on vitreous, aqueous and conjunctiva for 
the detection of cytomegalovirus in AIDS patients with a clinical 
diagnosis of cytomegalovirus retinitis from 24 patients who had 
untreated clinically diagnosed cytomegalovirus retinitis and from 15 
immunocompetent patients. Cytomegalovirus was detected in 16, 9 
and 3 of 24 vitreous, aqueous and conjunctival samples, from 
patients with AIDS, untreated clinically diagnosis of 
cytomegalovirus retinitis; and in one patient out of 15 vitreous, 
aqueous and conjunctival samples from immunocompetent patients  
with vitreoretinal disease. The use of PCR in the detection of 
cytomegalovirus in vitreous, aqueous and conjunctival samples had 
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an equal specificity of 93% and had sensitivity of 67, 37 and 12%, 
respectively4 7.   
 
Sowmya P et al  in 2006  standardized the optimal method of 
detection of CMV DNA by targeting three different regions of the 
genome using nested PCR for morphological transforming region 
(mtrII),   uniplex PCR for glycoprotein O (g O) and UL 83 gene in 
92 consecutive clinical specimens obtained from 74 
immunocompromised patients with clinically suspected CMV 
disease.  Based on pp65 antigenemia results as gold standard, the 
sensitivity, and specificity, positive predictive value and negative 
predictive value for each PCR was calculated. The PCR targeting 
mtr II region showed a higher sensitivity (100%) and negative 
predictive value (100%) than the other two PCRs in detecting CMV 
DNA45.   
 
Yamamoto et al  in 2006 evaluated the usefulness of saliva as a 
sample for the neonatal screening of congenital CMV infection as 
compared to urine when processed by PCR. Both saliva and urine 
samples were obtained from 1923 infants,  of these, 28 (1.45%) were 
CMV infected.  There was 99.7% agreement between the results with 
both samples. CMV excretion was similar when PCR was applied to 
urine (1.3%) or to saliva (1.2%) samples. They concluded that 
saliva samples are as useful for the identification of CMV DNA in 
large use for screening programs4 4.  
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Brantsaeter  et al  in 2007  attempted to demonstrate the diagnostic 
utility of CMV quantitative polymerase chain reaction in plasma 
from 125 HIV and CMV seropositive patients who died during the 
period of 1991 – 2002 and in whom autopsy was performed. Biopsy 
of relevant organs, stained with Hematoxylin and Eosin and 
confirmed with immunohistochemistry was done. Of 125 patients  
included, 53 had CMV disease, 37 of whom were first diagnosed at 
autopsy. Twenty seven of 53 patients with CMV disease (51%) and 
10 of 72 patients without CMV disease (14%) had detectable 
viraemia in the last plasma sample collected before death in atleast 
one sample. With a cut off at 10,000 copies per ml, specificity and 
positive predictive value were 100%. They concluded that 
quantitative CMV PCR is best used to rule in, rather than to rule out 
CMV disease in HIV infected individuals at high risk72.   
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STUDY GROUPS: 
GROUP I (n = 5):  
 Group I constituted 5 HIV seropositive patients as confirmed 
by western blot or Enzyme linked immunosorbent assay (ELISA). 
All the study participants comprised of males with the mean age  of  
34 ± 2.35 years.  
 
 The most common systemic lesions  constituted CMV retinitis  
(100%), the next manifestation commonly observed was tuberculosis 
(100%). All the subjects who were diagnosed with Tuberculosis 
were on antituberculosis medication. All patients in this group also 
had a history of hepatosplenomegaly and generalized 
lymphadenopathy. One patient had an added psychosis (APPENDIX 
1) as a complication due to the advanced stage of AIDS. 
  
 In the first group oral lesions comprised of gingivitis and 
dental caries (100%),non specific oral ulcers (20%), candidiasis 
(20%), angular chelitis  (20%), intra oral pigmentation (20%). Three 
of the patients in this group also complained of xerostomia (75%). 
(APPENDIX  3) 
 
 All the patients had CD4  counts less than 100 with a mean of 
67.8 cells per cubic mill imeter ± 23.18.Three of the five HIV 
seropositive subjects (60%) were on highly active anti retro viral 
therapy (HAART) comprising of 2 NRTI and 1 NRTI. HAART drugs 
were initiated 15 days, one month and three months respectively in 
three patients before their recruitment to this study. 
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GROUP II (n = 5): 
 In group II,  5 subjects, were HIV seronegative. This group 
also comprised of 5 males and the mean age  of the patients in this 
group was 28.20 years ± 4.76 years. All presented with CMV 
retinitis .  Oral lesions  comprised of gingivitis (100%), dental caries 
(100%), non specific ulcer (20%). Four patients had subjective 
complaints of xerostomia (80%) One patient had a history of renal 
transplantation one year back (20%) and was on prednisone acetate.  
 
CMV DNA EXTRACTION:   
 CMV DNA extraction was done from all the saliva samples as 
per the protocol detailed in the methodology. All the samples had 
more than 50ng/µl of DNA. 
 
VIRAL LOAD AND INTERPRETATION OF THE STUDY 
GRAPH: 
 Real Time PCR technique involves the amplification and 
detection of the viral load  “REAL TIME” i .e.  as the process is 
going on .   
 
The graph: The graph consists of an “x” and a “y” axis (Graph I,  
II).  The “x” axis represents the number of cycles in a PCR reaction. 
In our study 45 cycles was set as the reaction standard, a technique 
proven by  Madhavan et al in 200346 .  The “y” axis shows the range 
in which the flurophores (APPENDIX  2) exhibit excitement or the 
fluorescence intensity.   
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The standards: A  very accurate approach to absolute quantification 
is the use of competitive co-amplification of an internal control 
nucleic acid of known concentration (standards) and a wild type 
(samples) target nucleic acid of unknown concentration. 
 
 The ideal amplification curve of a real time PCR, when 
plotted as fluorescence intensity against the cycle number, is  a 
typical sigmoidal growth curve. Early amplification cannot be 
viewed because the detection signal is indistinguishable from the 
background. Under ideal conditions the amount of amplicon 
increases at a rate of one log 10 every three cycles. As the primers 
and enzymes become limiting and the products inhibitory to the 
PCR accumulate, the reaction slows, entering a transition phase 
(TP),  eventually reaching the plateau phase (PP)  where there is  
little or no further increase in the product yield. The point at which 
the fluorescence passes from insignificant levels to clearly 
detectable is called threshold cycle (CT), and this value is used in 
the calculation of template quantity during quantitative real – time 
PCR.. Higher the viral load, lower the threshold cycle value6 9. 
 
 In our study, 4 HIV seropositive samples and 2 HIV 
seronegative samples were run in the first phase of the experiment. 
(Graph1). In group I out of the 4 HIV seropositive samples placed 
in this reaction, two had a detectable viral load. They were Vrf 5736 
/10 which had a concentration threshold of 37.78 and a viral load of 
1,351 copies/ml and Vrf 5737/10 had threshold level of 24.11 and a 
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viral load of 5,386,741 copies/ml. There were no detectable viral 
loads in 2 samples of Group I and 2 samples of Group II.  
 
 In the second phase of experiment 1 HIV seropositive and 3 
HIV seronegative samples (Graph 2) were analyzed. In this phase 
only one sample i .e.  Vrf 6896 /10 which was the only HIV 
seronegative sample had a positive response with a concentration 
threshold of 12.58 and a viral load of 29,077,876 copies/ml. There 
were no detectable viral loads in one sample of Group I and 2 
samples of Group II.  
 
MEAN UNSTIMULATED SALIVARY FLOW RATE (USFR), 
QUESTIONNAIRE: 
 Unstimulated saliva was collected and measured in both group 
I and group II.  The standard USFR taken as 0.12 – 0.16 (Navasesh 
et al ,  1993)73 .  The mean unstimulated flow rate in group I was 
0.2080 ± 0.107, whereas in Group II it  was 0.3380 ± 0.194 (p = 
0.25). 
 
 Among the 18 questions (APPENDIX  3),  responses to 7 
questions which significantly contributed to ascertain xerostomia 
Balasundaram et al ,  2003  were analyzed and compared between the 
two groups.  The response to the question “is there a feeling of dry 
mouth always” was perceived more by group 1 (p = 0.15). 
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TABLE 1: INTERPRETATION OF RESULTS 
S no.  Colour Name Type Ct  
Given Conc 
(copies/ml) 
Calc Conc 
(copies/ml) 
% Var
1 
 
S  1  Standard 23.22 10,000,000 9 ,222,566 7 .8%
2 
 
S2 Standard 26.75 1,000,000 1 ,082,036 8 .2%
3 
 
S  3  Standard 30.54 100,000 108,883 8 .9%
4 
 
S  4  Standard 34.61 10,000 9 ,203 8 .0%
5 
 
Vrf  5736/10 Unknown 37.78  1 ,351  
6  
 
Vrf  5737/10 Unknown 24.11  5 ,386,741  
7  
 
Vrf  5738/10 Unknown     
8  
 
Vrf  5739/10 Unknown     
9  
 
Vrf  5740/10 Unknown     
10 
 
Vrf  5741/10 Unknown     
12 
 
NC NTC     
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TABLE 2: INTERPRETATION OF THE RESULTS 
No. Colour Name Type Ct  
Given Conc 
(copies/ml) 
Calc  Conc 
(copies/ml) 
% 
Var 
1  Std 1 Standard 12.66 25,000,000 24,786,286 0.9%
2  Std 2 Standard 13.85 2,500,000 2,543,297 1.7%
3  Std 3 Standard 15.06 250,000 247,863 0.9%
4  Vrf  
6893/10 
Unknown     
5   Vrf  
6894/10 
Unknown     
6   Vrf  
6895/10 
Unknown 24.37    
7   Vrf  
6896/10 
Unknown 12.58  29,077,876  
8  Nc NTC     
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 HIV/AIDS  is a symptom complex characterized by 
opportunistic infections which manifest secondary to the immune 
suppression. Oral lesions can precede the systemic lesions. They 
may rarely be the presenting or the only symptom in HIV infected 
patients and they can affect the quality of life in these patients.  Oral 
lesions may present in upto 50% of patients with HIV infection and 
in upto 80% of those with a diagnosis of AIDS. These lesions 
parallel the decline in CD4 cell counts and an increase in viral load. 
They are important indicators of disease progression and 
immunosuppression. Their importance has been demonstrated and 
emphasized by many researchers5 ,6 5. 
 
 CMV  is  a major cause of morbidity in patients with HIV 
infection. Despite treatment, CMV retinitis  causes substantial visual 
loss, especially in patients with a low CD4 count3 2. CMV has been 
implicated in the pathogenesis of intraoral ulcers and in salivary 
gland dysfunction in immunocompromised patients27.  There are 
studies where CMV was detected in intra oral ulcers by histological 
means, insitu hybridisation, immunohistochemistry and qualitative 
PCR 26 ,27 .  Very few studies have used the quantitative PCR to detect 
CMV DNA from the saliva in those with immunosuppression; 
Rhinow and  Schmidt-Westhausen 2003 quantitatively determined 
the CMV DNA in the saliva of 20 patients with bone marrow and 
stem cell transplantation6 9,  Craig S Miller et al  2006 investigated 
and calculated a prevalence of 34% in multiple human 
61 
 
herpsesviruses from the saliva by real time PCR of  HIV infected 
persons7 0  ,  Yoshikawa et al  in 2005 analyzed the shedding and 
quantified 3 beta herpesviruses including CMV  in the saliva of 
patients with connective tissue disorders7 1.  To our knowledge, this 
is  the first study in which CMV is quantitated in the saliva of HIV 
seropositive patients with CMV retinitis.   
 
 CMV is the largest member of the herpes family of viruses 
and is responsible for a significant percentage of asymptomatic viral 
infections worldwide. It  is estimated that upto 80% of all adults and 
94% of all homosexual men between the ages of 18 and 29 harbor 
antibodies to the CMV. The virus is endemic, because of its 
presence in every body fluid. CMV has been found in blood, breast 
milk, cervical secretions, saliva, semen, stool,  tears and urine of 
infected patients2 6.  Lucht et al  1998 attempted to detect CMV from 
the saliva of 44 HIV infected patients at different stages of disease 
and 15 healthy controls and concluded that the detection of CMV 
DNA in saliva correlated positively with severity of HIV 1 induced 
immunodeficiency51. In our study we have used saliva as a 
diagnostic tool  to detect and identify CMV DNA in all  the patients  
who presented with CMV retinitis and their CD4 counts were less 
than 100 cell /cumm. 
 
 CMV causes disseminated blood borne infection associated 
with endothelial cells,  mononuclear and polymorphonuclear 
leukocytes, it  is more commonly isolated from the plasma than in 
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saliva5 2.  Brantsaeter Arne and Holberg Mona – Peterson et al  in 
2007  demonstrated the diagnostic utility of CMV quantitative PCR 
in plasma from 125 HIV and CMV seropositive patients7 2.  
Pathanapitoon Kessara et al  in 2005  detected cytomegalovirus in 
AIDS patients with a clinical diagnosis of cytomegalovirus retinitis 
from 24 patients who had untreated clinically diagnosed 
cytomegalovirus retinitis and 15 immunocompetent patients4 7.  
 
 It  has been postulated that CMV can be detected in saliva if 
the virus disseminates to a salivary gland, Greenberg et al  in 1995  
could detect CMV DNA from the saliva of 60% of their study group 
(n = 10) to ascertain a link between CMV in saliva and salivary 
gland dysfunction in HIV infected patients27.  Greenberg et al  in 
1997 in their prospective study group detected a relationship 
between xerostomia and the presence of CMV in saliva of 13 
patients with HIV and a complaint of xerostomia and normal 
salivary flow rates8.  In our study,  the USFR ranged from 0.05 
ml/min to 0.32ml/min in group I and 0.06 to 0.57 ml/min in group 
II,  the least USFR was seen in the HIV seropositive patients with a 
viral load of 52,21,965 copies/ml and in one HIV seronegative 
patient with a viral load of 29,077,876 copies /ml.  We observed that 
the HIV seronegative patient also had a renal transplant and was on 
immunosuppressive therapy. This explains the high viral load and 
xerostomia in this patient.  These findings could probably suggest 
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the involvement of the salivary glands in our subjects by CMV 
infection, in concurrence with the report by  Greenberg et al .  
 
 As documented in literature, it has been postulated that CMV 
is an important causative virus leading to ulceration of the 
mucocutaneous region. The finding of CMV in the endothelial cells  
of these ulcers could be a reflection of systemic vasculopathy or it  
may be directly contributing to the focal ulcerative process either as 
a causative factor or a maintenance factor26.  In our study intra  oral 
ulcerations was observed in one patient in the HIV positive group 
who had a CMV viral load of 52, 21,965 copies/ml. Similarly  
Williams et al  in 1960  reported the first case of intra oral CMV 
where they described oral ulcerations in a HIV seropositive man, 
the ulcerations involved the upper and lower lips. The patient 
expired one month after the development of the oral ulcerations. 
Langford et al  in 1990  also observed four patients with oral 
ulcerations associated with disseminated cytomegalovirus in HIV 
patients Lucht and Brytting et al  in 1998 observed the presence of 
CMV DNA in the saliva of 44 HIV infected patients with intra oral 
ulcerations49 ,3 3.  Anne Cale Jones et al  in 1993  reported 6 cases of 
CMV affecting the oral cavity, one disease involving bone, one 
associated with KS, one with histoplasmosis and the rest with 
herpes simplex2 9 .  
 
 In our study, one HIV seronegative patient had oral ulcers 
with a CMV viral load of 29,077,876 copies /ml, who also 
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underwent renal transplantation a year back. This is in concurrence 
with López-Pintor RM, Hernández et  al  in 2009 who reported 6 
cases of intra oral ulcers in renal transplant patients who were HIV 
seronegative6 8.   
 
 There was no detectable viral load  in the saliva of the other 
patients (Group I: 3 HIV seropositive; Group II: 4 HIV 
seronegative) inspite of their positive CMV retinitis.  Masaru Ihira 
et al  in 2003,  could isolate CMV DNA only from 92 of 279 saliva 
samples of subjects who were HIV positive, and could not elicit  a  
response from other subjects and attributed the same to possible 
PCR inhibitors in saliva, Greenberg et al  in 1997  isolated CMV 
DNA from 6 out of 10 saliva samples and attributed the lack of 
expression in the remaining 4 to PCR inhibitors60 ,8 .  Rocha, Vargas 
et al  in 2008 found an elevated expression of salivary leukocyte 
proteinase inhibitor, (SLPI) in the mucosal secretions of AIDS 
patients and stated that the absence of CMV viral shedding in the 
saliva which could be due to increased expression of SLPI6 1.  The 
absence of viral shedding in saliva and its consequent 
undetectability by the real time PCR machine could also be 
explained by the possible ocular tropism of the virus and limited 
ability of dissemination in the blood thus leading to poor 
aggregation in the salivary gland thus reduced salivary shedding. 
 
 It  has been postulated that  CMV induced oral ulcerations  can 
be used as a forerunner  before the systemic manifestations of  CMV ;  
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Dodd et al in 1993  had reported a case of intra oral ulceration in a 
35 year old male patient,  where the oral manifestation appeared six 
weeks before the diagnosis of CMV retinitis3 1.  In another case 
report Berman and Jenson et al  in 1990  isolated and identified 
CMV inclusions in the lesional endothelial cells from an infected 
area in the mandible of a HIV seropositive patient3 4.  The same 
patient had later  developed CMV retinitis  
 
 In our study, the CMV viral load was above the threshold 
level in subjects with intra oral ulcers and those who had 
xerostomia as confirmed by their responses to the questionnaire and 
USFR. This initial study was designed to ascertain the correlation of 
CMV virus and oral findings. Though there are limitations to this 
study, we state that CMV infection in HIV seropositive patients  
affects the salivary glands and manifests as non specific ulcers 
intraorally. Thus, we hypothesize that the non specific ulcers should 
be studied further and their role as a potential forerunner of CMV 
retinitis  be investigated especially in those patients who present 
with xerostomia. Our study also establishes that saliva could be 
recommended as a diagnostic tool for quantifying CMV. 
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 This study was done to detect and quantify CMV in the saliva 
of HIV seropositive and seronegative patients with active CMV 
retinitis .  
• 5 HIV seropositive and 5 HIV seronegative patients were 
included in the study. 
• All the study participants were males.  
• Mean age of the patients in the study group was 35.12 ±  2 
years and in control group, it  was 28.7 ± 5 years.  
• Oral ulcers were present in two patients,  one in Group I and 
one in Group II. 
• DNA extraction was done from all the samples and quantified 
for cytomegalovirus 
• CMV DNA was quantified in the saliva in 2 samples in group 
I and 1 sample in group II above the threshold limit using the 
Real Time – PCR. 
• Saliva can be used as an diagnostic tool to assess the CMV 
infection. 
 
 In our study, patients with CMV retinitis who had intraoral 
non-specific ulcers and xerostomia had significant CMV viral load 
as detected by Real Time PCR. We hypothesize that non specific 
ulcers not responding to regular treatment, in immunocompromised 
patients could be indicative of CMV retinitis and associated 
morbidity.  We also conclude that saliva could be recommended as a 
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diagnostic tool for quantifying CMV viral load especially in those 
patients who present with xerostomia and oral ulcers. 
 
 More studies are necessary in order to enhance the methods 
used to detect CMV DNA and the sample collection techniques, so 
as to shed more light on the CMV infection and its prevalence in the 
oral cavity of HIV seropositive patients.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
68 
 
1. Weinert M,Grimes RM,Lynch DP 
Oral  manifestations of HIV infection 
Ann Int Med .  1996; 125: 485 -496 
2. Ranganathan K, Hemalatha R 
Oral Lesions in HIV Infection in Developing Countries: an 
Overview 
Advances in Dental Research  2006, 19: 63 - 68. 
3. Ranganathan K, Umadevi M, Saraswathi TR, Kumaraswamy 
N, Solomon S 
Oral lesions and conditions associated with human 
immunodeficiency virus infection in 1000 South – Indian 
patients 
Ann Acad Med Singapore  2004,33 (suppl): 37 -  42,.  
4. Deborah G, John S G 
HIV – related oral disease   
Lancet 1996, 348, 729 -33. 
5. Sandra F, Catherine M F. 
Oral warts in HIV – Infected individuals 
RITAI September  2000;6:3 
6. Epstein JB, Silverman S, Jr. 
Head and Neck malignancies associated with HIV infection. 
Oral surg Oral Med Oral Pathol  1992; 73: 193 -200 
7. Glenn J  
Cytomegalovirus infections following renal transplantation.  
Rev. Infect.  Dis  1981, 3:1151-1178. 
69 
 
8. Greenberg MS, Glick M, Nghiem L, Stewart JC, Hodinka R 
Relationship of cytomegalovirus to salivary gland dysfunction in 
HIV infected patients. 
Oral surg Oral Med Oral Pathol  1997; 83: 334 -339 
9. Schoidt M 
HIV associated salivary gland disease: a review. 
Oral surg oral med oral pathol  1992; 73: 164 -7 
10.Schoidt M, Greenspan D, Daniels TE 
Parotid gland enlargement and xerostomia associated with labial  
sialadenitis in HIV infected patients. 
J Autoimmune  1989;2: 415 -25 
11.Betty FA 
Acquisition of Cytomegalovirus Infection: an Update 
Clinical Microbiology Reviews  1989; 4: 204-216 
12.David M M, Willem VDF, Annelies VR, Charles F 
Immune reconstitution inflammatory syndrome (IRIS): review of 
common infectious manifestations and treatment options 
AIDS Research and Therapy 2007: 4;9 
13.Oram JD, Downing RG, Akrigg A, Dollery AA, Duggleby G 
Use of recombinant plasmids to investigate the structure of the 
human cytomegalovirus genome.  
J. Gen. Virol .  1982: 59;111-129. 
14.Stinski MF, Thomsen DR, Stenberg RM,  Goldstein LC   
Organization and expression of the immediate early genes of 
human cytomegalovirus. 
70 
 
J. Virol.  1983.46:1-14. 
15.Petros RI, Eleni MG, Ioannis VC 
Severe cytomegalovirus infection in apparently 
immunocompetent patients: a systemic review 
Virology Journal 2008, 5:47 
16.Wreghitt T.G,Teare E.L, Sule. O, Devi. R, Rice.P 
Cytomegalovirus Infection in Immunocompetent Patients 
Clinical Infectious Diseases  2003; 37: 1603 -6 
17.Tarkan JL, Woo SB, Pavlakis M, Johnson SR, Chrieac LR, 
Chimienti SN 
Spotting the owl: surreptitious cytomegalovirus disease in a 
renal transplant reciepient  
Clin Transplant  2008: 22: 391 – 395 
18.David H, Ford N, Wilson D, Rodriguez WR  
Cytomegalovirus retinitis: the neglected disease of the aids 
pandemic 
Plos Medicine December  2007: 4:12: e334 
19.Doumas S, Vladikas A, Papagianni  M, Kolokotronis A 
Human cytomegalovirus – associated oral and maxilla – facial 
disease 
Clin Microbiol Infect  2007; 13: 557 – 559 
20.Lambert EM, John S, Rossitza L, Richard AJ 
Cytomegalovirus Ulcer 
Arch Dermatol  2004:140; 1199 - 1201 
 
71 
 
21.Vargas PA, Mauad T, Bohm GM, Saldiva PHN, Almeida OP 
Parotid gland involvement in advanced AIDS 
Oral Diseases  2003: 9; 55 – 61 
22.John KH, Dougla JA, Laura WA, James DP, Shiela WK 
Mortality risk for patients with cytomegalovirus retinitis and 
acquired immune deficiency syndrome 
Clinical infectious diseases  2003; 37: 1365 – 73 
23.Hosey MT, Davison SM, Gordan G, Shaw L, Kelly DA.  
Cytomegalovirus and cyclosporin induced gingival overgrowth in 
children with liver grafts 
International Journal of Pediatric Dentistry 2002; 12; 236 – 243 
24.Esteban D, Guadalupe F, Javier F, Laura C, Amaro G  
Mucocutaneous presence of cytomegalovirus associated with 
human immunodeficiency virus infection 
Arch Dermatol  2001; 137:443-448 
25.Patra S, Samal SC, Ashok C, Mathan VI, Mathan M 
Cytomegalovirus infection of the human gastrointestinal tract 
Journal of Gastroenterology and Hepatology  1999: 14; 973 – 976 
26.Leimola – Virtanen RE, Happonen RP, Syranjen SM.  
Cytomegalovirus (CMV) and helicobacter pylori (HP) found in 
oral mucosal ulcers. 
J Oral Pathol Med  1995 
 
 
 
72 
 
27.Martin GS, Dubin G, Stewart JCB, Christopher GC, Rob RMG 
Relationship of oral disease to the presence of cytomegalovirus 
DNA in the saliva of AIDS patients. 
Oral Pathol Oral Radiol Endod  1995: 79; 175 - 9 
28.Glick M, Muzyka BC, Lurie D, Salkin LM  
Oral manifestations associated with HIV related disease as 
markers for immune suppression and aids. 
Oral Surg Oral Med Oral Pathol  1994: 77; 344 – 9 
29.Jones AC, Freedman PD, Phelan PD, Baughman RA, Kerpel SM 
Cytomegalovirus infections of the oral cavity. A report of six 
cases and review of literature. 
Oral Surg Oral Med Oral Pathol  1993: 75; 76 – 85 
30.Pedersen A, Hornsleth A 
Recurrent apthous ulceration: a possible clinical manifestation of 
reactivation of varicella zoster or cytomegalovirus infection 
Oral Pathol Med  1993: 22; 64 - 66 
31.Dodd CL, Winkler JR, Heinic GS, Daniels TE, Yee K, 
Greenspan D 
Cytomegalovirus infection presenting as acute periodontal 
infection in a patient infected with the human immunodeficiency 
virus. 
J Clin Periodontol  1993: 20; 282 – 285 
32.Leggot PJ. 
Oral manifestations of HIV infection in children 
Oral Surg Oral Med, Oral Pathol  1992; 73: 187 – 92 
73 
 
33.Langford A, Kunze R, Timm H, Ruf B, Reichert P 
Cytomegalovirus associated oral ulcerations in HIV infected 
patients 
J Oral Pathol Med  1990; 19: 71 – 6 
34.Berman S, Jensen J 
Cytomegalovirus induced osteomyelitis  in a patient with the 
acquired immunodeficiency syndrome 
South Med J  1990 Oct; 83:10: 1231 – 2 
35.Muller M, Wandek S, Colebunders R, Attia S, Hansjakob F  
Immune reconstitution inflammatory syndrome in patients  
starting antiretroviral therapy for HIV infection: a systemic 
review and meta analysis 
The Lancet  2010:10; 251 -261 
36.Kartik K Venkatesh, Biswas J, Kumarasamy N 
Impact of highly active antiretroviral therapy on ophthalmic 
manifestations in human immunodeficiency virus/ acquired 
immune deficiency syndrome 
Indian J Ophthalmology  2008; 56: 391 – 3 
37.Ortega KL,  Ceballos SA, Gaitan  CLA, Magalhaes MG 
Oral manifestations after immune reconstitution in HIV patients  
on HAART. 
International journal of STD & AIDS:  2008; 19: 305 – 308 
38.Majumadar S, Mandal SK, Banyaopadhyay D, Roy CS, 
Chakroborty PP, Mitra K 
74 
 
Multiorgan involvement due to cytomegalovirus infection in 
AIDS 
Brazilian Journal of Infectious Diseases  2007: 11;1: 176 – 178 
39.Rao M 
Cytomegalovirus infection after the renal transplantation – the 
indian experience 
Indian J Nephrol  2002; 12: 16 – 24 
40.Karavellas MP, Plummer DJ, Macdonald JC, Torriani FJ, 
Shufelt CL, Azen SP Freeman WR 
Incidence of immnune recovery vitritis in cytomegalovirus 
retinitis  patients following institution of successful highly active 
antiretroviral therapy. 
The Journal  of Infectious Diseases  1999; 179: 697 – 700 
41.Cassoux N, Bodaght B, Katlama C, LeHoang P 
CMV retinitis in the era of HAART 
Ocular immunology and inflammation  1999:7; 3 – 4, 231 – 235 
42.Meer S, Altini M 
Cytomegalovirus Co-infection in AIDS-associated Oral Kaposi’s 
Sarcoma 
Adv Dent Res 2006; 19: 96 – 100 
43.Correia Jdef, Victoria JNM, Guimaraes ALS, Salomao UE 
Cytomegalovirus shedding in the oral cavity of allogenic 
hematopoietic stem cell transplant patients 
Oral diseases  2007: 13; 163 – 169 
 
75 
 
44.Yamamoto AY, Mussi PMM, Marin LJ, Rosangela MB 
Birth Prevalence and Natural History of Congenital 
Cytomegalovirus (CMV) Infection in a Highly Seroimmune 
Population 
Journal of Clinical Virology  2006: Vol 36; 3,228 – 230 
45.Sowmya P, Madhavan HN and Therese KL 
Evaluation of three polymerase chain reaction tests targeting 
morphological transforming region ii ,  ul 83dgene and 
glycoprotein o gene for the detection of human cytomegalovirus 
genome in clinical specimens of immunocompromised patients in 
chennai, India. 
Virology Journal  2006, 3:20 - 24 
46.Priya K, Madhavan HN, Malathi J 
Use of uniplex polymerase chain reaction and evaluation of 
multiplex PCR in the rapid diagnosis of viral retinitis 
Indian J Med Res  2003:117; 205 – 210 
47.Pathanapitoon K, Ausayakhu S, Paradee K, Arporn P, Wasna S 
Detection of cytomegalovirus in vitreous, aqueous and conjuctiva 
by polymerase chain reaction (PCR) 
J Med Assoc Thai  2005: 88; 2: 228 – 32 
48.Ammatuma P, Campisi G, Giovannelli  L, Giambelluca D, 
Alaimo C, Mancuso S 
Presence of Epstein Barr virus, cytomegalovirus and human 
papillomavirus in normal oral mucosa of HIV infected and renal 
transplant patients.  
Oral Diseases  2001; 7: 34 – 40 
76 
 
49.Lucht E, Brytting M, Bjerregaard L, Julander I,  Linde A 
Shedding of cytomegalovirus and Herpesvirus 6,7 and 8 in saliva 
of Human Immunodeficiency Virus Type 1 – Infected Patients 
and Healthy Controls 
Clinical Infectious Diseases  1998: 27; 137 – 41 
50.Boivin G, Handfield J, Toma E, Murray G, Lalonde R 
Comparative evaluation of the cytomegalovirus DNA load in 
polymorphonuclear leukocytes and plasma of human 
immunodeficiency virus infected subjects. 
Journal of Infectious Diseases  1998: 177; 355 – 60 
51.Warren WP, Balcarek K, Smith R, Pass RF. 
Comparison of rapid methods of detection of cytomegalovirus in 
saliva with virus isolation in tissue culture 
Clinical Microbiology  1992: 30; 4; 786 – 789 
52.Boland GJ, De WR, Tilanus MGJ, Ververs C, Bosboom KK, 
De Gast GC 
Detection of cytomegalovirus in granulocytes by polymerase 
chain reaction compared with the CMV antigen test 
Journal of Clinical Microbiology 1992: 30:7; 1763 -1767 
53.Howden BP, Michaelides A, Spelman DW, Spencer A, 
Schwarer  AP, Wesselingh S  
Cytomegalovirus viral load monitoring after allogeneic bone 
marrow transplantation in patients receiving antiviral 
prophylaxis 
Bone Marrow Transplantation 2003: 32; 795–800 
77 
 
54.Spector SA, Hsia K, Crager M, Pilcher M, Sheila C, Mary JS 
Cytomegalovirus (CMV) DNA Load Is An Independent Predictor 
Of CMV Disease And Survival In Advanced Aids 
Journal Of Virology 1999: 73; 8; 7027–7030 
55.Humar A, Gregson D, Caliendo AM, McGeer A, Malkan G, 
Krajden M, Corey P 
Clinical utility of quantitative cytomegalovirus viral load 
determination for predicting cytomegalovirus disease in liver 
transplant recipients. 
Transplantation  1999: 15;68:9:1305-11 
56.Patton LL, McKaig RG, Strauss RP, Rogers D, Eron JJ, Hill C 
Oral manifestations of HIV in a southeast USA population. 
Oral Diseases  1998; 4:164-9 
57.Patton LL 
HIV disease 
Dental Clinics of North America  2003: 47; 467–492 
58.Kubar A, Saygun I, Yapar M, Ozdemir A, Slots J 
Real-time PCR quantification of cytomegalovirus in aggressive 
periodontitis lesions using TaqMan technology. 
J Periodontal Res 2004: 39;2:81-6  
59.Sabeti M, Daneshmand A, Simon JH, Slots J 
Cytomegalovirus-infected inflammatory cells in dental periapical 
lesions.  
Oral Microbiol Immunol  2009: 24; 434–6 
78 
 
60.Masaru I, Tetsushi Y, Masahiro O, Yoshihiko E, Shiho A, 
Sadao S, Hiroh S 
Variation of Human Herpesvirus 7 Shedding in Saliva 
The Journal of Infectious Diseases  2003; 188:1352–4  
61.Rocha LA, Vargas PA, Silva JE Leon, Santos AB, Hiemstra 
PS, Mauad T 
Expression of secretory leukocyte proteinase inhibitor in the 
submandibular glands of AIDS patients 
Oral Diseases  2008:14; 1;82–88  
62.Ryan KJ, Ray CG   
Sherris Medical Microbiology  2004:4t h Edition 
Mc Graw – Hill  Book Publishers 
63.Offermanns S, Rosenthal W   
Encyclopedia of Molecular Pharmacology  2008: 2nd ed., 437–
438 
Springer publications 
64.Calogero C, Silvio B, Giuseppina C, Giuseppina Colonna-
Romano, Deborah DW 
Mechanisms of immunosenescence 
Immunity & Ageing 2009, 6:10 
65.Emmanuel B, Jan C, Erwin VE, Marjan VE  
Infectious Mononucleosis–Like Syndromes in Febrile Travelers 
Returning From the Tropics 
Journal of Travel Medicine 2006:13; 4:191–197  
 
79 
 
66.Kubar A, Saygun I, Yapar M, Ozdemir A, Slots J  
Real-time PCR quantification of cytomegalovirus in aggressive 
periodontitis lesions using TaqMan technology. 
J Periodontal Res  2004: 39:2;81-6 
67.Ian MM, Katherine EA, Andreas N  
Real – time PCR in Virology 
Nucleic Acids Research  2002: 30;6; 1292 -1305 
68.López RM, Hernández G, Arriba L, Morales JM, Jiménez C  
Oral ulcers during the course of cytomegalovirus infection in 
renal transplant recipients            
Transplant Proc.  2009; 41:6:2419-21. 
69.Rhinow K, Schmidt-Westhausen AM, Ellerbrok H, Pauli G  
Quantitative determination of CMV-DNA in saliva of patients 
with bone marrow and stem cell transplantation using TaqMan-
PCR 
Mund Kiefer Gesichtschir .  2003 :7;6:361-4 
70. Miller CS, Berger JR, Yunanan MS, Avdiushko A, Hua Z 
High Prevalence of Multiple Human Herpesviruses in Saliva 
from Human Immunodeficiency Virus-Infected Persons in the Era 
of Highly Active Antiretroviral Therapy 
Journal of Clinical Microbiology  2006, 4; 7; 2409–2415 
71.  Yoshikawa T,Masaru I, Hiroaki T, Shunji Y, Yoshizo A  
Analysis of Shedding of 3 b-Herpesviruses in Salivafrom 
Patients with Connective Tissue Diseases 
The Journal of Infectious Diseases  2005; 192:1530–6 
80 
 
72.Brantsaeter AB, Holberg MP, Jeansson S, Goplen AK, Bruun JN 
CMV quantitative PCR in the diagnosis of cmv disease in 
patients with HIV infection – a retrospective autopsy based study 
BMC Infectious Diseases  2007: 7; 127 
73. Navazesh M  
Methods for collecting Saliva 
Annals of New York Academy of Sciences 1993: 694; 72-74  
74. Mujtaba S, Varma S, Sehgal S. 
Cytomegalovirus co infection in patients with HIV / AIDS in 
north India 
Indian J Med Res  2003:117; 99 – 103 
 
 
 
  
APPENDIX 1 
Antiviral medications for CMV 
infections 
Foscarnet, 
Ganciclovir  
Cidofovir  
Psychosis   (from the Greek "psyche", for 
mind/soul, and - "-osis", for 
abnormal condition) means 
abnormal condition of the mind, 
and is a generic psychiatric term 
for a mental state often 
described as involving a "loss of 
contact with reality 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
APPENDIX 2 
CMV Cyto MegaloVirus 
R Reagents 
S Quantitation standards 
W   Molecular Grade Water 
Supermix 
 
Supermix contains dntps (Deoxyribonucleotide 
triphosphate) ,  
Buffer, 
Forward and reverse primers, 
Probes and 
Taq  DNA polymerase 
Magnesium 
Chloride 
 
Magnesium forms a complex with dNTP's, 
which is a substrate of the polymerase enzymes.
Inhibition control  
 
Inhibition Control Gene allows the user to 
determine & control possible PCR inhibition. 
The results can be visualized in the Joe 
channel. 
Oligonucleotides An oligonucleotide is a short nucleic acid 
polymer, typically with fifty or fewer bases. 
fluorophore causes a molecule to be fluorescent.  It  is  a 
functional group in a molecule which will 
absorb energy of a specific wavelength and re-
emit energy at a different (but equally specific) 
wavelength. 
FAM (for the 
pathogen)  
Flurophore range: 470nm to 510nm6-
carboxyfluorescein ,  (GREEN) 
JOE Flurophore range:530nm  – 555nm  (YELLOW) 
ROX Flurophore range:585nm  –  610nm  (ORANGE) 
CY5 Flurophore range:625nm -  660nm  (RED) 
QUASAR 705 Flurophore range:680nm  – 710nm (CRIMSON) 
Real-time quantitative real time polymerase chain reaction
  
polymerase chain 
reaction synonyms  
 kinetic polymerase chain reaction 
Internal 
amplification 
control (IAC) / use 
of standards 
 
 
The IAC included in the Reaction Mix system 
has been designed to validate the accuracy of 
the test,  enabling the distinction of true 
negative results from false negative results 
caused by PCR malfunction (due to inhibition, 
spoilage of the PCR reagents). 
The IAC system consists of the independent 
amplification of an artificial DNA sequence, 
which is co‐amplified with the pathogen target 
DNA during the PCR run. The IAC is 
incorporated into the Reaction Mix to a 
concentration that has been carefully adjusted.  
   
  
APPENDIX 3 
Xerostomia inventory  
Often my mouth feels dry Never Occasionally Frequently Always 
I sip liquids to aid in 
swallowing 
Never Occasionally Frequently Always 
I get up in night to drink 
water 
Never Occasionally Frequently Always 
My mouth feels dry while 
eating  
Never Occasionally Frequently Always 
My mouth feels dry 
always 
Never Occasionally Frequently Always 
Difficulty while eating Never Occasionally Frequently Always 
I suck cough lollies Never Occasionally Frequently Always 
Difficulty in swallowing 
certain foods 
Never Occasionally Frequently Always 
Skin of my face feels dry Never Occasionally Frequently Always 
My eyes feel dry Never Occasionally Frequently Always 
My lips feel dry Never Occasionally Frequently Always 
The inside of my nose 
feels dry 
Never Occasionally Frequently Always 
Burning sensation in gums Never Occasionally Frequently Always 
Burning sensation in 
tongue 
Never Occasionally Frequently Always 
I feel itching sensation in 
gums 
Never Occasionally Frequently Always 
I feel itching sensation in 
mouth 
Never Occasionally Frequently Always 
I feel taste alterations Never Occasionally Frequently Always 
I feel itching sensation in 
gums 
Never Occasionally Frequently Always 
 
